课题基金 / 基金详情

Epigenetic predictors of outcome in malignant glioma

Epigenetic predictors of outcome in malignant glioma
恶性神经胶质瘤结果的表观遗传学预测因子
批准号:
nhmrc : 1049609
负责人:
A/Pr Elizabeth Algar
金额:
$46.52万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2016-12-31

项目摘要

项目成果

A/Pr Elizabeth Algar的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Human high grade gliomas (HGG) present as heterogeneous disease, primarily defined by the histologic appearance of the tumor cells.Glioblastoma multiforme (GBM) is the most common illness and continues to have a very poor prognosis, despite the use of multimodality therapy including surgery, radiation therapy and chemotherapy. We will use our existing biobank of specimens, clinical information and molecular investigation to identify factors that determine outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular mechanisms in beckwith wiedemann syndrome
  • 批准号:
    nhmrc : 981045
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $14.09万
  • 财政年份:
    1998
  • 负责人:
    A/Pr Elizabeth Algar
  • 依托单位:
海外基金